[EXPERIENCE OF APPLICATION OF THE GENE INDUCTOR OF VASCULAR ENDOTHELIUM GROWTH FACTOR IN TREATMENT OF PATIENTS,...

The results of examination of patients, suffering chronic ischemia of the lower extremities (LE) stages IIB - III (according to Fontaine), in whom preparation Neovasculgen was used in complex of medicinal therapy, were presented. In terms of follow-up before 12 months the distance, which the patients passed before the pain occurrence, have enhanced by 92.2%, and the ankle-brachial index--by 30.9%. Complications while application of the preparation were absent. Due to the treatment conducted there were LE saved and the patients' quality of life improved.